申请人:Kazantsev Aleksey G.
公开号:US20100069372A1
公开(公告)日:2010-03-18
The present invention is based, in part, on assays we conducted that revealed compounds that modulate (e.g., inhibit) PARP-1 and are therefore useful in treating or preventing diseases characterized by abnormal PARP-1 activity (e.g., undesirable PARP-1 activity).